It was approved by the US Food and Drug Administration (FDA) to speed up the process of producing the vaccine against COVID-19 Moderna, allowing it to fill a vial of up to 15 doses as the United States bets on rapidly immunizing its population to stem the spread of the new coronavirus.
The FDA also approved the export of a maximum of 11 doses from today’s Moderna vaccine vials, instead of the 10 allowed until now.
In a statement, Moderna, as reported by AMPE, notes that the supply of its vaccine can now be done in vials containing 11 or 15 doses and that it expects to start sending vials with 15 doses in the coming weeks.
“Both of these reviews have a positive effect on his supply Moderna COVID-19 vaccine, which will help provide more vaccine doses to communities and allow faster doses of the vaccine, “said Peter Marks, director of the FDA Center for Organic Product Evaluation and Research.
However, the FDA has warned that without proper syringes and needles it may not be possible to extract more than 13 doses from the 15-dose vials of the Moderna vaccine, as well as more than 10 doses from current vials.
Moderna had supplied the United States with 100 million doses of its vaccine by March 29. Pfizer / BioNTech and Johnson & Johnson’s COVID-19 vaccines are the other two approved in the country.
At a time when cases are rising and some states even go as far as removing the mandatory use of a protective mask, Health authorities hope that contracts with US-approved vaccine manufacturers will be sufficient to cover the entire population.
Leading US epidemiologist Anthony Fauci told Reuters on Thursday that the country may not need the AstraZeneca COVID-19 vaccine, even if it receives approval from the US regulator.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
